Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia

被引:281
作者
Wierda, William G.
O'Brien, Susan
Wang, Xuemei
Faderl, Stefan
Ferrajoli, Alessandra
Do, Kim-Anh
Cortes, Jorge
Thomas, Deborah
Garcia-Manero, Guillermo
Koller, Charles
Beran, Miloslav
Giles, Francis
Ravandi, Farhad
Lerner, Susan
Kantarjian, Hagop
Keating, Michael
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2005-12-051458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical course for patients with chronic lymphocytic leukemia is extremely heterogeneous. The Rai and Binet staging systems have been used to risk-stratify patients; most patients present with early-stage disease. We evaluated a group of previously untreated patients with chronic lymphocytic leukemia (CLL) at initial presentation to University of Texas M. D. Anderson Cancer Center to identify independent characteristics that predict for overall survival. Clinical and routine laboratory characteristics for 1674 previously untreated patients who presented for evaluation of CLL from 1981 to 2004 were included. Univariate and multivariate analyses identified several patient characteristics at presentation that predicted for overall survival in previously untreated patients with CLL. A multivariate Cox proportional hazards model was developed, including the following independent characteristics: age, beta-2 microglobulin, absolute lymphocyte count, sex, Rai stage, and number of involved lymph node groups. Inclusion of patients from a single institution and the proportion of patients younger than 65 years may limit this model. A weighted prognostic model, or nomogram, predictive for overall survival was constructed using these 6 characteristics for 5- and 10-year survival probability and estimated median survival time. This prognostic model may help patients and clinicians in clinical decision making as well as in clinical research and clinical trial design.
引用
收藏
页码:4679 / 4685
页数:7
相关论文
共 41 条
[1]  
BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO
[2]  
2-V
[3]   Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas [J].
Brennan, MF ;
Kattan, MW ;
Klimstra, D ;
Conlon, K .
ANNALS OF SURGERY, 2004, 240 (02) :293-298
[4]   PROGNOSTIC FACTORS IN CHRONIC LYMPHOCYTIC-LEUKEMIA - THE IMPORTANCE OF AGE, SEX AND RESPONSE TO TREATMENT IN SURVIVAL - A REPORT FROM THE MRC CLL 1 TRIAL [J].
CATOVSKY, D ;
FOOKS, J ;
RICHARDS, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) :141-149
[5]   GUIDELINES FOR CLINICAL PROTOCOLS FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - RECOMMENDATIONS OF THE NATIONAL-CANCER-INSTITUTE-SPONSORED-WORKING-GROUP [J].
CHESON, BD ;
BENNETT, JM ;
RAI, KR ;
GREVER, MR ;
KAY, NE ;
SCHIFFER, CA ;
OKEN, MM ;
KEATING, MJ ;
BOLDT, DH ;
KEMPIN, SJ ;
FOON, KA .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 29 (03) :152-163
[6]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[7]  
Cox D. R., 1989, Analysis of Binary Data, V2nd
[8]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[9]   CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia [J].
D'Arena, G ;
Musto, P ;
Cascavilla, N ;
Dell'Olio, M ;
Di Renzo, N ;
Perla, G ;
Savino, L ;
Carotenuto, M .
LEUKEMIA & LYMPHOMA, 2001, 42 (1-2) :109-114
[10]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847